CHRISTINA CRUZ: Open Payments
NPI 1255067427 · AIRMONT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 33 payments from 17 companies in 2025. Trend: 2023 $15 · 2024 $0 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $141 |
| Janssen Biotech, Inc. | 1 | $96 |
| Amgen Inc. | 3 | $88 |
| LNHC, Inc | 1 | $87 |
| Incyte Corporation | 3 | $66 |
| UCB, Inc. | 2 | $50 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
Products named: DUPIXENT, TREMFYA, OTEZLA, ZELSUVMI, OPZELURA, Bimzelx, Zoryve, EBGLYSS.
Industry payments across NY — which companies pay providers there.
